Back to Stakeholders
Funding & InvestmentFoundations & PhilanthropyGrant-Making Organizations
Funding & InvestmentFoundations & Philanthropy
Funding & Investment

Schweizerischer Nationalfonds

Switzerland
2 Trials

The Swiss National Science Foundation (Schweizerischer Nationalfonds, SNF) is Switzerland's principal public funder of scientific research across all academic disciplines; in the psychedelic field, it has funded multiple clinical trials including psilocybin studies for alcohol use disorder and major depressive disorder, contributing to Switzerland's position as the world's second-largest hub for psychedelic clinical research with over 35 trials and a historic connection to Albert Hofmann's discovery of LSD and isolation of psilocybin at Basel.

Foundations & Philanthropy Snapshot

Grant-Making Organizations

Classification

Public Charity / Non-Profit

Geography

Global

Coverage

Global

Last Verified

Apr 10, 2026

Funding Focus Areas

Academic Research Funding

Support Types

Grant Funding

Philanthropy Notes

Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Verification Notes

Verified against official SNSF funding pages.

Primary Funding Link

Source Evidence

Schweizerischer Nationalfonds website

https://www.snf.ch

Swiss National Science Foundation

https://www.snf.ch

SNSF Funding

https://www.snf.ch/en/funding

Quick Facts

Type
Other
HQ
Switzerland
Website
Visit

Collaborated Trials

2
CompletedII

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

Start Date
Compounds
Psilocybin, Placebo
CompletedII

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients – Proof of Concept

Start Date
Compounds
Psilocybin, Placebo